Retour
37
Fourchette du Jour
41,88 €
43,25 €
Fourchette 52 Semaines
34,89 €
50,88 €
Volume
3 917 678
Moyenne 50J / 200J
44,71 €
/
44,03 €
Clôture Précédente
42,73 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 29,8 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | 8,5 | 3,8 |
| Net Margin % | 4,1 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 1,2 | 0,2 |
Objectif de Cours des Analystes
Hold
48,59 €
+14.4%
Low: 38,00 €
High: 56,00 €
P/E Prévisionnel
28,9
BPA Prévisionnel
1,47 €
Croissance BPA (est.)
+0,0%
CA Est.
31 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,39 €
2,37 € – 2,41 €
|
41 B | 3 |
| FY2029 |
2,12 €
2,10 € – 2,14 €
|
38 B | 3 |
| FY2028 |
1,85 €
1,75 € – 2,08 €
|
36 B | 9 |
Points Clés
Generating 1,74B in free cash flow
Cash machine — converts 150,47% of earnings into free cash flow
Capital efficient — spends only 0,00% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)11,47%
Earnings (1Y)-3,42%
FCF Growth (3Y)11,61%
Qualité
Return on Equity
8,50%
ROIC7,12%
Net Margin4,08%
Op. Margin7,78%
Sécurité
Debt / Equity
1,17
Current Ratio4,29
Interest Coverage0,00
Valorisation
P/E Ratio
29,75
P/B Ratio3,21
EV/EBITDA20,39
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,47% | Revenue Growth (3Y) | 10,63% |
| Earnings Growth (1Y) | -3,42% | Earnings Growth (3Y) | 122,55% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 28,43B | Net Income (TTM) | 1,16B |
| ROE | 8,50% | ROA | 3,01% |
| Gross Margin | 26,44% | Operating Margin | 7,78% |
| Net Margin | 4,08% | Free Cash Flow (TTM) | 1,74B |
| ROIC | 7,12% | FCF Growth (3Y) | 11,61% |
| Safety | |||
| Debt / Equity | 1,17 | Current Ratio | 4,29 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 29,75 | P/B Ratio | 3,21 |
| P/S Ratio | 1,21 | PEG Ratio | -4,97 |
| EV/EBITDA | 20,39 | Dividend Yield | 0,00% |
| Market Cap | 34,48B | Enterprise Value | 45,10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 28,43B | 25,51B | 23,23B | 21,45B |
| Net Income | 1,16B | 1,20B | 234,00M | -25,00M |
| EPS (Diluted) | 1,43 | 1,52 | 0,30 | -0,03 |
| Gross Profit | 7,52B | 6,29B | 5,22B | 4,56B |
| Operating Income | 2,21B | 2,23B | 1,44B | 870,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 38,48B | 35,98B | 36,12B |
| Total Liabilities | 19,20B | 19,45B | 19,15B |
| Shareholders' Equity | 10,74B | 16,52B | 16,98B |
| Total Debt | 12,56B | 16,90B | 16,83B |
| Cash & Equivalents | 1,94B | 250,00M | 1,59B |
| Current Assets | 10,68B | 8,27B | 8,81B |
| Current Liabilities | 2,49B | 2,44B | 2,13B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#689 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026